NCT07342920 Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
| NCT ID | NCT07342920 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Cystic Fibrosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-10-15 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the collective unconscious, a patient with cystic fibrosis does not smoke. This belief is so deeply rooted that there is virtually no French data on the prevalence of smoking among this vulnerable population. Faced with a cohort of patients undergoing a complete transformation (improved quality of life and life expectancy, fewer hospitalizations, reduced respiratory symptoms, better social integration), it is becoming urgent to assess the current situation in order to optimize tobacco prevention. This is all the more important given the emergence of international studies objectively examining the interactions between smoking, vaping, and the efficacy of Kaftrio.
Eligibility Criteria
Inclusion Criteria: * Adult patient (≥ 18 years old) * With confirmed cystic fibrosis * Regular follow-up at the Strasbourg Adult Cystic Fibrosis Center Exclusion Criteria: * Patients who have undergone a double lung transplant for cystic fibrosis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07342920 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cystic Fibrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342920 currently recruiting?
Yes, NCT07342920 is actively recruiting participants. Contact the research team at Romain.Kessler@chru-strasbourg.fr for enrollment information.
Where is the NCT07342920 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07342920 clinical trial?
NCT07342920 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.